Leslie K. Ballas, MD, discusses the background and design for the phase 2 BRIGHT trial, evaluating a risk-adapted bladder preservation strategy in MIBC.
Leslie K. Ballas, MD
Advertisement
Articles by Leslie K. Ballas, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
The ArteraAI Prostate Test: What It Is and How It Works
2
HHS requests testosterone therapy label updates, citing new safety data
3
Retrospective study suggests differences in OAB therapy persistence among older adults
4
Unmet needs and emerging solutions in MRI-guided prostate cancer care
5